BlackRock Inc. - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 165 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$3,343,389
+29.3%
3,482,697
+1.0%
0.00%
Q1 2023$2,586,359
+81.1%
3,448,478
-11.0%
0.00%
Q4 2022$1,427,830
-54.0%
3,874,707
-46.3%
0.00%
Q3 2022$3,105,000
-49.5%
7,219,167
-8.4%
0.00%
Q2 2022$6,146,000
-69.8%
7,878,203
-50.1%
0.00%
-100.0%
Q1 2022$20,367,000
-46.9%
15,789,223
-47.7%
0.00%0.0%
Q4 2021$38,374,000
-42.3%
30,215,947
-1.0%
0.00%
-50.0%
Q3 2021$66,559,000
-41.2%
30,531,435
+1.1%
0.00%
-33.3%
Q2 2021$113,230,000
+23.3%
30,194,887
+7.2%
0.00%0.0%
Q1 2021$91,844,000
-3.2%
28,173,428
+1.3%
0.00%0.0%
Q4 2020$94,868,000
-12.2%
27,820,979
+5.1%
0.00%
-25.0%
Q3 2020$107,989,000
+64.8%
26,468,194
+36.5%
0.00%
+33.3%
Q2 2020$65,536,000
+53.8%
19,389,487
+6.0%
0.00%
+50.0%
Q1 2020$42,611,000
-37.8%
18,287,393
-2.9%
0.00%
-33.3%
Q4 2019$68,558,000
-54.6%
18,834,593
+3.4%
0.00%
-50.0%
Q3 2019$151,027,000
+0.0%
18,207,055
+3.8%
0.01%0.0%
Q2 2019$151,009,000
-15.7%
17,538,995
+4.6%
0.01%
-25.0%
Q1 2019$179,168,000
+23.8%
16,760,341
+1.4%
0.01%
+14.3%
Q4 2018$144,676,000
-51.7%
16,534,252
-7.2%
0.01%
-46.2%
Q3 2018$299,375,000
-13.6%
17,820,045
+7.8%
0.01%
-18.8%
Q2 2018$346,411,000
+42.9%
16,527,226
+9.7%
0.02%
+33.3%
Q1 2018$242,379,000
-20.0%
15,063,977
-5.8%
0.01%
-14.3%
Q4 2017$303,008,000
+79.8%
15,989,930
+33.5%
0.01%
+55.6%
Q3 2017$168,522,000
+97.9%
11,977,334
+4.8%
0.01%
+80.0%
Q2 2017$85,176,000
+12.2%
11,432,990
-2.1%
0.01%
+25.0%
Q1 2017$75,891,000
+51177.7%
11,675,780
+34892.0%
0.00%
Q4 2016$148,000
-8.1%
33,367
-3.2%
0.00%
Q3 2016$161,000
-26.8%
34,464
+2.6%
0.00%
Q2 2016$220,000
+609.7%
33,605
+589.6%
0.00%
Q1 2016$31,000
+181.8%
4,873
+153.3%
0.00%
Q4 2015$11,000
-54.2%
1,924
-53.3%
0.00%
Q3 2015$24,000
+71.4%
4,124
+114.3%
0.00%
Q2 2015$14,000
+27.3%
1,9240.0%0.00%
Q1 2015$11,000
-21.4%
1,9240.0%0.00%
Q4 2014$14,000
-12.5%
1,9240.0%0.00%
Q3 2014$16,0000.0%1,9240.0%0.00%
Q2 2014$16,000
+6.7%
1,9240.0%0.00%
Q1 2014$15,000
-11.8%
1,9240.0%0.00%
Q4 2013$17,000
+6.2%
1,9240.0%0.00%
Q3 2013$16,000
+6.7%
1,9240.0%0.00%
Q2 2013$15,0001,9240.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 787,973$615,0000.77%
CM Management, LLC 600,000$468,0000.50%
ARMISTICE CAPITAL, LLC 17,100,000$13,338,0000.23%
Sargent Investment Group, LLC 614,600$479,0000.15%
Ergoteles LLC 744,275$581,0000.02%
Sonora Investment Management Group, LLC 103,000$80,0000.01%
CAXTON ASSOCIATES LP 107,135$84,0000.01%
MCDONALD PARTNERS LLC 42,570$33,0000.01%
Pinz Capital Management, LP 15,600$12,0000.01%
D. E. Shaw & Co., Inc. 8,051,858$6,281,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders